European Union Authorizes COVID-19 Vaccine From US-Based Novavax

The European Medicines Agency is seen in Amsterdam, Netherlands on April 20, 2021. Peter Dejong/AP Photo

The European Union’s executive branch on Monday authorized Novavax’s COVID-19 vaccine, enabling its use in all 27 member-states.

The European Commission previously cleared four COVID-19 vaccines, but Novavax’s, known as Nuvaxovid, is the first protein-based one.